Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, November 2008, p. 4159-4162, Vol. 52, No. 11
0066-4804/08/$08.00+0 doi:10.1128/AAC.01633-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Plasmid-Mediated Quinolone Resistance Determinants qnrA, qnrB, and qnrS among Clinical Isolates of Enterobacteriaceae in a Korean Hospital
Migma Dorji Tamang,
Sung Yong Seol,
Jae-Young Oh,
Hee Young Kang,
Je Chul Lee,
Yoo Chul Lee,
Dong Taek Cho, and
Jungmin Kim*
Department of Microbiology, Kyungpook National University School of Medicine, 101 Dongin-dong-2 ga, Jung-gu, Daegu 700-422, Republic of Korea
Received 19 December 2007/
Returned for modification 9 March 2008/
Accepted 13 August 2008

ABSTRACT
Screening of 368 consecutive nonreplicate clinical isolates
of
Enterobacteriaceae resistant to nalidixic acid and at least
one extended-spectrum β-lactam revealed the presence of
qnrA,
qnrB, and
qnrS determinants, and identified novel
qnrB variants, in
Citrobacter freundii isolates. This study also
revealed, for the first time, the linkage of
qnrB,
armA, and
extended-spectrum and/or AmpC-type β-lactamase genes on
large conjugative plasmids.

TEXT
Since the first plasmid-mediated quinolone resistance (PMQR)
was reported in 1998 for a
Klebsiella pneumoniae isolate from
the United States (
10), three PMQR mechanisms have been discovered.
The first PMQR mechanism involves
qnr genes that have been reported
worldwide in various enterobacterial species (
2,
4,
5,
7,
9,
10,
13,
18,
23,
24). The second consists of the AAC(6')-Ib-cr
gene, which encodes a new variant of the common aminoglycoside
acetyltransferase that is capable of acetylating the piperazinyl
substituent of some fluoroquinolones (
20) and thereby reducing
their activities. A novel plasmid-mediated fluoroquinolone efflux
pump protein, QepA, has recently been reported simultaneously
from Japan (
26) and Europe (
16) as the third PMQR mechanism.
A strong association of quinolone resistance with the production
of extended-spectrum β-lactamases (ESBLs) or plasmid-mediated
AmpC β-lactamases (pACBLs) has been observed (
7,
9,
13,
18,
24). The association between
qnrA and ESBL determinants
for SHV-5 (
12,
24), SHV-7 (
24), CTX-M-9 (
23), CTX-M-14 (
2),
CTX-M-15 (
7), and VEB-1 (
17) or pACBL determinants for DHA-1
(
13,
24) and FOX-5 (
10) has been reported repeatedly. Similarly,
qnrB has been reported to be located on plasmids carrying
bla genes for CTX-M-15, SHV-12 (
7), or SHV-30 (
4) ESBLs. In Korea,
recent studies have shown a strong association between
qnrB4 and
blaDHA-1 in members of the
Enterobacteriaceae (
14,
15).
In this study, the prevalences of the three major families of qnr determinants, and the association of qnr genes with ESBL, pACBL, and/or plasmid-mediated 16S rRNA methylase genes, among 368 nonduplicate clinical isolates of Enterobacteriaceae resistant to nalidixic acid and at least one of the extended-spectrum β-lactams (cefoxitin, cefotaxime, cefepime, aztreonam, or ceftazidime), consecutively collected during 2004 to 2006 at Kyungpook National University Hospital in the Republic of Korea, were investigated.
The qnrA, qnrB, and qnrS genes were detected by multiplex PCR as described previously (19). A total of 141 (38.3%) isolates were qnr positive. Each of the three qnr families was detected, but none of the isolates harbored two or more types of qnr genes simultaneously. The qnrA, qnrB, and qnrS genes were detected in 4 (1.0%), 135 (36.7%), and 2 (0.5%) of the total isolates, respectively. The qnrB determinants were most commonly detected in Citrobacter freundii isolates (67.9%), followed by K. pneumoniae (62.5%), Enterobacter cloacae (15.8%), and Escherichia coli (9.4%) isolates. While qnrA was detected only in E. cloacae isolates, qnrS was detected in one K. pneumoniae and one E. coli isolate (Table 1). The high prevalence of qnrB in this study is in good agreement with the findings of previous studies conducted in Korea (14) and Taiwan (25).
View this table:
[in this window]
[in a new window]
|
TABLE 1. Distribution of bla ESBL and/or pACBL and armA genes among clinical isolates of Enterobacteriaceae according to qnr determinantsa
|
All
qnrA and
qnrS amplicons were confirmed by sequencing. The
sequences of the four
qnrA amplicons were identical to that
of
qnrA1 from
K. pneumoniae plasmid pMG252 (
10), and those of
the two
qnrS amplicons were identical to that of
qnrS1 from
Shigella flexneri 2b plasmid pAH0376 from Japan (
5). A restriction
fragment length polymorphism (RFLP) protocol was developed in
conjunction with the multiplex PCR, as outlined in Fig.
1, to
differentiate between
qnrB variants. RFLP analysis of the PCR
products obtained from 135
qnrB-positive isolates revealed several
variants, including 15 (4%)
qnrB1, 1 (0.2%)
qnrB2, 113 (30.7%)
qnrB4, and 2 (0.5%)
qnrB6 amplicons, and four original RFLP
profiles that did not match with variants detectable by this
typing protocol. Sequencing of the
qnrB2 and
qnrB6 amplicons
and of representatives of the
qnrB1 (
n = 5) and
qnrB4 (
n = 10)
amplicons confirmed their identities. In order to determine
the sequences of the
qnrB genes yielding unique RFLP profiles,
primers QnrB-1-10-F (ATGACGCCATTACTGTATAAAAAA) and QnrB-1-10-R
(CTAGCCAATAATCGCGATGCCA) were used to obtain a 681-bp PCR product.
In addition to direct sequencing of amplicons obtained with
the original genomic DNA, the corresponding amplicons were cloned
into a pGEM-T vector (Promega, Madison, WI) and sequenced, and
their sequences were confirmed and compared with known sequences
by using the BLAST programs at the National Center for Biotechnology
Information (
http://www.ncbi.nlm.nih.gov/BLAST). Three novel
qnrB variants, which exhibited 97 to 98% nucleotide sequence
identity and >98% amino acid identity with each other, were
identified among the
C. freundii strains (Fig.
2). As proposed
in the recently published Commentary on Qnr numbering by Jacoby
et al. (
6), they are designated
qnrB13,
qnrB14, and
qnrB15,
respectively, and each of them codes for a 214-amino-acid protein.
qnrB13 exhibits the highest degrees of nucleotide (98.9%) and
amino acid (99.5%) sequence identity to
qnrB2 (GenBank accession
no. DQ351242), whereas
qnrB14 and
qnrB15 exhibit the highest
degrees of nucleotide (97.7%) and amino acid (99.1%) sequence
identity to
qnrB9 (GenBank accession no. EF526508).
A multiplex PCR to identify
blaSHV,
blaCTX-M-1-like, and
blaCTX-M-9-like
genes and simplex PCRs to identify the
blaDHA-1 gene and 16S
rRNA methylase genes (
rmtA,
rmtB, and
armA) were carried out
with clinical isolates and their transconjugants as described
previously (
3,
8,
27). The distribution of these other resistance
determinants among the
qnr-positive clinical isolates of
Enterobacteriaceae is shown in Table
1. Of the 141
qnr-positive isolates, ESBL
and/or pACBL genes were detected in 122 (86.5%). However, no
ESBL and/or pACBL gene was detected among the 19
C. freundii isolates carrying
qnrB variants. Upon further investigation,
it was found that three of these isolates produced a β-lactamase
with a pI of 5.4, consistent with
blaTEM-1, a finding that was
also corroborated by nucleotide sequencing of their PCR products
(data not shown). The
armA gene was detected in 100 (70.9%)
qnr-positive clinical isolates (Table
1), all of which were
resistant to amikacin. The other 16S rRNA methylase genes (
rmtA,
rmtB, and
rmtC) investigated were never found. Overall, 96 isolates
of
Enterobacteriaceae simultaneously carried
qnrB4,
blaDHA-1,
armA, and
blaSHV-12 with or without other ESBL genes.
By conjugation using the liquid mating method (22) at 37°C, qnr determinants carried by qnr-positive clinical isolates were transferred to E. coli J53 Azir or E. coli RG488 Rifr recipients. Transconjugants were selected on Mueller-Hinton agar (Difco) plates supplemented with ampicillin (32 µg/ml) and sodium azide (200 µg/ml) or rifampin (50 µg/ml). Conjugal transfer for ampicillin resistance was successful for 70 donor isolates. However, only 32% (43 qnrB4, 2 qnrB6, and 1 qnrS isolate) of the total donor isolates transferred qnr determinants. The apparent lack of transfer of qnr determinants for the remaining 68% of the isolates could be due to their presence on nonconjugative plasmids. Alternatively, it could be due to their chromosomal location, as a result of integration of the qnr-carrying plasmid back into the chromosome. Further study should be done to prove this hypothesis. MICs were determined by the agar dilution method (11). The MICs of nalidixic acid and ciprofloxacin for the qnr-positive transconjugants were as much as severalfold higher than those for the recipients (Table 2). The transconjugants carrying qnrB6 and qnrS1 exhibited the highest increases in MICs. Overall, 35 transconjugants simultaneously carried qnrB4, blaDHA-1, blaSHV-12, and armA with or without other ESBL genes (Table 2). PCR-based inc replicon typing, performed for the 46 qnr-positive transconjugants using boiled DNA templates, as described previously (1), identified FIIAs, FIA, and L/M plasmids in 32, 3, and 1 transconjugant, respectively, all of which were qnrB4 positive, except for 2 that were positive for qnrB6 and qnrS1, respectively (Table 2).
Isolation of plasmid DNA from nine randomly selected transconjugants
positive for
qnrB4 (of which six also carried the
blaDHA-1,
blaSHV-12, and
armA genes, and three carried different combinations
of two of these genes) by the alkaline lysis method (
21) revealed
a large plasmid of approximately 180 kb. Southern hybridization
using probes specific for the
qnrB4,
blaDHA-1,
blaSHV-12, and
armA genes revealed that all determinants were apparently carried
on the same plasmid (Fig.
3). The plasmids derived from the
transconjugants were similar in size, belonged to the FIIAs
inc type, and carried the
qnrB4,
blaDHA-1,
blaSHV-12, and
armA genes. Furthermore, Southern hybridization of the plasmid DNAs
isolated from the two transconjugants positive for
qnrB6,
blaDHA-1,
and
armA determinants revealed that the determinants were apparently
carried on the same large plasmid (data not shown). However,
another, relatively smaller, nonconjugative plasmid was also
hybridized with a probe specific for
qnrB6 in addition to the
large conjugative plasmid, indicating the presence of
qnrB6 on two plasmids of different sizes in the same clinical strain
but not in the corresponding transconjugants (data not shown).
Thus, the spread of multidrug-resistant
Enterobacteriaceae simultaneously
carrying the
qnrB,
blaDHA-1,
blaSHV-12, and
armA genes was due
mainly to dissemination of a large
inc FIIAs conjugative plasmid.
Although the spread of multidrug-resistant
E. coli and
K. pneumoniae isolates that produce both ESBLs and 16S rRNA methylases has
been reported (
27), and several reports have also demonstrated
the association between
qnr determinants and the ESBL and/or
pACBL genes (
7,
9,
13,
18,
24), the association between
qnr determinants, ESBL and/or pACBL genes, and 16S rRNA methylase
genes on the same conjugative plasmid had never been reported
before.
In conclusion, this is the first report of the simultaneous
association of
qnrB,
armA, and ESBL and/or AmpC β-lactamase
genes on large conjugative plasmids found in clinical isolates,
which consequently were resistant to almost all clinically important
antimicrobial agents.
Nucleotide sequence accession numbers.
The nucleotide sequences of the novel qnrB variants in C. freundii strains 05K657, 05K1560, 06K619, and 06K1424, determined in this study, have been submitted to GenBank and have been assigned accession no. EU273755, EU273756, EU273757, and EU302865, respectively.

ACKNOWLEDGMENTS
This work was supported by a grant from the Korean Health 21
R&D project, Ministry of Health and Welfare, Republic of
Korea (03-PJ1-PG1-CH03-0002), and in part by the Brain Korea
21 Project (2007).

FOOTNOTES
* Corresponding author. Mailing address: Department of Microbiology, Kyungpook National University School of Medicine, 101 Dongin-dong-2 ga, Jung-gu, Daegu 700-422, Republic of Korea. Phone: 82-53-420-4845. Fax: 82-53427-5664. E-mail:
minkim{at}knu.ac.kr 
Published ahead of print on 25 August 2008. 

REFERENCES
1 - Carattoli, A., A. Bertini, L. Villa, V. Falbo, K. L. Hopkins, and E. J. Threlfall. 2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63:219-228.[CrossRef][Medline]
2 - Cheung, T. K., Y. W. Chu, M. Y. Chu, C. H. Ma, R. W. Yung, and K. M. Kam. 2005. Plasmid-mediated resistance to ciprofloxacin and cefotaxime in clinical isolates of Salmonella enterica serotype Enteritidis in Hong Kong. J. Antimicrob. Chemother. 56:586-589.[Abstract/Free Full Text]
3 - Chia, J. H., C. Chu, L. H. Su, C. H. Chiu, A. J. Kuo, C. F. Sun, and T. L. Wu. 2005. Development of a multiplex PCR and SHV melting-curve mutation detection system for detection of some SHV and CTX-M beta-lactamases of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae in Taiwan. J. Clin. Microbiol. 43:4486-4491.[Abstract/Free Full Text]
4 - Gay, K., A. Robicsek, J. Strahilevitz, C. H. Park, G. Jacoby, T. J. Barrett, F. Medalla, T. M. Chiller, and D. C. Hooper. 2006. Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica. Clin. Infect. Dis. 43:297-304.[CrossRef][Medline]
5 - Hata, M., M. Suzuki, M. Matsumoto, M. Takahashi, K. Sato, S. Ibe, and K. Sakae. 2005. Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob. Agents Chemother. 49:801-803.[Abstract/Free Full Text]
6 - Jacoby, G., V. Cattoir, D. Hooper, L. Martínez-Martínez, P. Nordmann, A. Pascual, L. Poirel, and M. Wang. 2008. qnr gene nomenclature. Antimicrob. Agents Chemother. 52:2297-2299.[Free Full Text]
7 - Jacoby, G. A., K. E. Walsh, D. M. Mills, V. J. Walker, H. Oh, A. Robicsek, and D. C. Hooper. 2006. qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrob. Agents Chemother. 50:1178-1182.[Abstract/Free Full Text]
8 - Kim, J., and Y. M. Lim. 2005. Prevalence of derepressed AmpC mutants and extended-spectrum β-lactamase producers among clinical isolates of Citrobacter freundii, Enterobacter spp., and Serratia marcescens in Korea: dissemination of CTX-M-3, TEM-52, and SHV-12. J. Clin. Microbiol. 43:2452-2455.[Abstract/Free Full Text]
9 - Li, X. Z. 2005. Quinolone resistance in bacteria: emphasis on plasmid-mediated mechanisms. Int. J. Antimicrob. Agents 25:453-463.[CrossRef][Medline]
10 - Martínez-Martínez, L., A. Pascual, and G. A. Jacoby. 1998. Quinolone resistance from a transferable plasmid. Lancet 351:797-799.[CrossRef][Medline]
11 - National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th ed. Approved standard M7-A6. National Committee for Clinical Laboratory Standards, Wayne, PA.
12 - Nazic, H., L. Poirel, and P. Nordmann. 2005. Further identification of plasmid-mediated quinolone resistance determinant in Enterobacteriaceae in Turkey. Antimicrob. Agents Chemother. 49:2146-2147.[Free Full Text]
13 - Nordmann, P., and L. Poirel. 2005. Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J. Antimicrob. Chemother. 56:463-469.[Abstract/Free Full Text]
14 - Pai, H., M. R. Seo, and T. Y. Choi. 2007. Association of QnrB determinants and production of extended-spectrum β-lactamase or plasmid-mediated AmpC β-lactamase in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 51:366-368.[Abstract/Free Full Text]
15 - Park, Y. J., J. K. Yu, S. Lee, E. J. Oh, and G. J. Woo. 2007. Prevalence and diversity of qnr alleles in AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii, and Serratia marcescens: a multicentre study from Korea. J. Antimicrob. Chemother. 60:868-871.[Abstract/Free Full Text]
16 - Périchon, B., P. Courvalin, and M. Galimand. 2007. Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli. Antimicrob. Agents Chemother. 51:2464-2469.[Abstract/Free Full Text]
17 - Poirel, L., M. Van De Loo, H. Mammeri, and P. Nordmann. 2005. Association of plasmid-mediated quinolone resistance with extended-spectrum β-lactamase VEB-1. Antimicrob. Agents Chemother. 49:3091-3094.[Abstract/Free Full Text]
18 - Robicsek, A., G. A. Jacoby, and D. C. Hooper. 2006. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect. Dis. 6:629-640.[CrossRef][Medline]
19 - Robicsek, A., J. Strahilevitz, D. F. Sahm, G. A. Jacoby, and D. C. Hooper. 2006. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob. Agents Chemother. 50:2872-2874.[Abstract/Free Full Text]
20 - Robicsek, A., J. Strahilevitz, G. A. Jacoby, M. Macielag, D. Abbanat, C. H. Park, K. Bush, and D. C. Hooper. 2006. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat. Med. 12:83-88.[CrossRef][Medline]
21 - Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed., p. 1.32. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
22 - Tamang, M. D., J. Y. Oh, S. Y. Seol, H. Y. Kang, J. C. Lee, Y. C. Lee, D. T. Cho, and J. Kim. 2007. Emergence of multidrug-resistant Salmonella enterica serovar Typhi associated with a class 1 integron carrying the dfrA7 gene cassette in Nepal. Int. J. Antimicrob. Agents 30:330-335.[CrossRef][Medline]
23 - Wang, M., D. F. Sahm, J. A. Jacoby, and D. C. Hooper. 2004. Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob. Agents Chemother. 48:1295-1299.[Abstract/Free Full Text]
24 - Wang, M., J. H. Tran, G. A. Jacoby, Y. Zhang, F. Wang, and D. C. Hooper. 2003. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob. Agents Chemother. 47:2242-2248.[Abstract/Free Full Text]
25 - Wu, J. J., W. C. Ko, S. H. Tsai, and J. J. Yan. 2007. Prevalence of plasmid mediated quinolone resistance determinants qnrA, qnrB, and qnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital. Antimicrob. Agents Chemother. 51:1223-1227.[Abstract/Free Full Text]
26 - Yamane, K., J. I. Wachino, S. Suzuki, K. Kimura, N. Shibata, H. Kato, K. Shibayama, T. Konda, and Y. Arakawa. 2007. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob. Agents Chemother. 51:3354-3360.[Abstract/Free Full Text]
27 - Yan, J. J., J. J. Wu, W. C. Ko, S. H. Tsai, C. L. Chuang, H. M. Wu, Y. J. Lu, and J. D. Li. 2004. Plasmid-mediated 16S rRNA methylases conferring high-level aminoglycoside resistance in Escherichia coli and Klebsiella pneumoniae isolates from two Taiwanese hospitals. J. Antimicrob. Chemother. 54:1007-1012.[Abstract/Free Full Text]
Antimicrobial Agents and Chemotherapy, November 2008, p. 4159-4162, Vol. 52, No. 11
0066-4804/08/$08.00+0 doi:10.1128/AAC.01633-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Carattoli, A.
(2009). Resistance Plasmid Families in Enterobacteriaceae. Antimicrob. Agents Chemother.
53: 2227-2238
[Full Text]